Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chinese biotech hamstrung by production issues

Nature Biotechnology volume 25, pages 147–148 (2007)Cite this article

China's fast-developing biopharmaceutical industry is encountering a scale-up and production bottleneck.

“The production issue is quite important,” says Qihong Sun, a scientist at the Beijing-based Academy of Military Medical Sciences. “If it is not properly handled, [China's] progress in biotech research could be discounted.” Sun was referring specifically to delays in getting several biotech drugs made in China onto the market, long after their approval by regulators.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Author information

Authors and Affiliations

  1. Beijing

    Hepeng Jia

Authors
  1. Hepeng Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Poor enforcement could jeopardize China's drug innovation policy

Handle with care

Lack of private financing hobbles emerging biotech regions

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jia, H. Chinese biotech hamstrung by production issues. Nat Biotechnol 25, 147–148 (2007). https://doi.org/10.1038/nbt0207-147

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0207-147

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing